The FDA is Dead Wrong in its Review of Mailed Abortion Pill Safety
The abortion drug Mifepristone (Mifeprex) entered the U.S. market in 2000. For the past two decades, the drug’s official labeling stated some permutation of the following: Mifeprex…Administration must be under the supervision of a qualified physician –and– Mifeprex may be administered only in a clinic, medical office, or hospital, by or under the supervision of … Read more